International – Clinical Trials During COVID-19: Updates From FDA, MHRA and TGA

The US Food and Drug Administration (FDA) last week updated its guidance from earlier this month on conducting clinical trials during the coronavirus disease (COVID-19) pandemic.
 
The update comes as other regulatory authorities offer updates on managing new or ongoing clinical trials during the outbreak and as pharma companies have begun to halt or alter ongoing trials. Both European Medicines Agency (EMA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) have provided their own guidance on conducting clinical trials amid during the outbreak, with EMA also offering methodological considerations for impacted trials…